Latham Leads H1 2025 Capital Markets League Tables
Firm’s Capital Markets Practice once again earns top legal advisor league table rankings across debt and equity products and industries globally in Bloomberg, Dealogic, Deal Point Data, and LSEG.
Anthony Gostanian represents both public companies and underwriters, with a focus on the life sciences industry, in a variety of capital-raising and M&A transactions, as well as securities law compliance and corporate governance matters.
Anthony advises a number of leading San Diego-based clinical-stage public biotech and life sciences companies on their most important strategic transactions, as well as public company representation matters, including:
Anthony also advises investment banks on capital market offerings by biotech and life sciences companies.
Anthony regularly represents public biotech and life sciences companies in corporate governance and securities law compliance matters, as well as strategic transactions, including:
Anthony routinely advises leading investment banks, such as JPMorgan, Jeffries, and SVB Leerink, as underwriters in public equity offerings, including for:
Author, “How the FDA Can Overturn Wyeth v. Levine,” 36 American Journal of Law & Medicine 248, 2010
Firm’s Capital Markets Practice once again earns top legal advisor league table rankings across debt and equity products and industries globally in Bloomberg, Dealogic, Deal Point Data, and LSEG.
Chambers USA recognized the firm as a “powerhouse in the capital markets space.”
Chambers USA recognized the firm’s Mergers & Acquisitions Practice for “world class expertise when it comes to the most challenging transactions.”